Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01791478
Title BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements Yes
Sponsors Vanderbilt-Ingram Cancer Center

Her2-receptor negative breast cancer


Alpelisib + Letrozole

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Massachusetts General Hospital, Dana-Farber Cancer Institute Boston Massachusetts 02114 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232-6838 United States Details
*Shaded cells indicate that there was no data available from for the field